F997-0657 Screening compound: N-(4-methoxyphenyl)-3,5-dimethyl-N-({4-[(morpholin-4-yl)methyl]thiophen-2-yl}methyl)-1,2-oxazole-4-sulfonamide

F997-0657 Screening compound: N-(4-methoxyphenyl)-3,5-dimethyl-N-({4-[(morpholin-4-yl)methyl]thiophen-2-yl}methyl)-1,2-oxazole-4-sulfonamide
F997-0657 Screening compound: N-(4-methoxyphenyl)-3,5-dimethyl-N-({4-[(morpholin-4-yl)methyl]thiophen-2-yl}methyl)-1,2-oxazole-4-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F997-0657
N-(4-methoxyphenyl)-3,5-dimethyl-N-({4-[(morpholin-4-yl)methyl]thiophen-2-yl}methyl)-1,2-oxazole-4-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F997-0657

Molecular Formula

C22H27N3O5S2 (C22 H27 N3 O5 S2)

Compound Name

N-(4-methoxyphenyl)-3,5-dimethyl-N-({4-[(morpholin-4-yl)methyl]thiophen-2-yl}methyl)-1,2-oxazole-4-sulfonamide

IUPAC name

N-(4-methoxyphenyl)-35-dimethyl-N-({4-[(morpholin-4-yl)methyl]thiophen-2-yl}methyl)-12-oxazole-4-sulfonamide

SMILES

Cc1noc(C)c1S(N(Cc1cc(CN2CCOCC2)cs1)c(cc1)ccc1OC)(=O)=O

InChI

InChI=1S/C22H27N3O5S2/c1-16-22(17(2)30-23-16)32(26,27)25(19-4-6-20(28-3)7-5-19)14-21-12-18(15-31-21)13-24-8-10-29-11-9-24/h4-7,12,15H,8-11,13-14H2,1-3H3

InChI Key

QVVSBYJXSYUEMB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14974107

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.61

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.454

Distribution Coefficient, logD

1.349

Water Solubility, LogSw

-2.75

Polar Surface Area

74.034

Acid Dissociation Constant (pKa)

27.24

Base Dissociation Constant (pKb)

8.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

F997-0657 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F997-0657 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F997-0657?
Check Price and Availability of F997-0657, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F997-0657 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F997-0657
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F997-0657
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F997-0657 available by request